Biosimilars

Lupus. 2020 May;29(6):525-532. doi: 10.1177/0961203320910797. Epub 2020 Mar 18.
No abstract available

Keywords: Biosimilars; systemic lupus erythematosus; update.

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Biosimilar Pharmaceuticals / therapeutic use*
  • Clinical Trials, Phase III as Topic
  • Drug Approval
  • Drug Development
  • Humans
  • Lupus Erythematosus, Systemic / drug therapy*
  • Lupus Erythematosus, Systemic / economics
  • Rituximab / therapeutic use

Substances

  • Antibodies, Monoclonal, Humanized
  • Biosimilar Pharmaceuticals
  • Rituximab
  • belimumab